Research
Genome writing reveals SVA retrotransposon consequences in X-linked dystonia-parkinsonism
Cell · By Weimin Zhang, Yu Zhao, Priya Prakash, Heather Appleby, Kelly Barriball, Simona Capponi, Qingwen Jiang, Aleksandra M. Wudzinska, Jordan R. Westerdahl, Alan Mejia Maza, Kathryn Mangiameli, Christine A. Vaine, Gwen Ellis, Neha Rahman, Stefan Markovic, Orin Mishkit, Kerry C. Limberg, Matthew T. Maurano, Youssef Z. Wadghiri, Sang Y. Kim, Vanessa C. Wheeler, H.T. Marc Timmers, D. Cristopher Bragg, Shane A. Liddelow, Ran Brosh & Jef D. Boeke ·
The Brief
- Researchers humanized the mouse Taf1 locus with an XDP patient-derived allele using genomic conditional editing.
- The mouse model recapitulates key molecular and neuropathological features of X-linked dystonia-parkinsonism.
- Intronic SVA retrotransposon transcription impairs TAF1 expression and drives striatal degeneration.
Why it matters
It identifies a specific mechanism, SVA transcription reducing TAF1 expression, behind striatal degeneration in XDP, and provides a mouse model for studying the disease.
Who’s affected
- neurogenetics and neurodegeneration researchers
- people affected by X-linked dystonia-parkinsonism and their families
- #xdp
- #taf1
- #retrotransposon
- #neurodegeneration
- #genome editing
- #dystonia
Genomic conditional humanization of the mouse Taf1 locus with an XDP patient-derived allele recapitulates key molecular and neuropathological features of XDP, revealing that intronic SVA transcription impairs TAF1 expression and drives striatal degeneration. CRISPRa-mediated Taf1…